Michael G Silverman1, Michael J Blaha2, Harlan M Krumholz3, Matthew J Budoff4, Ron Blankstein5, Christopher T Sibley6, Arthur Agatston7, Roger S Blumenthal2, Khurram Nasir8. 1. The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD, USA Brigham and Women's Hospital, Cardiovascular Division, Boston, MA, USA. 2. The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD, USA. 3. Section of Cardiovascular Medicine and the Robert Wood Johnson Clinical Scholars Program, Department of Internal Medicine, Yale University School of Medicine, and Section of Health Policy and Administration, Yale School of Public Health; and the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA. 4. Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, CA, USA. 5. Brigham and Women's Hospital, Cardiovascular Division, Boston, MA, USA. 6. National Institutes of Health, Bethesda, MD, USA. 7. Center for Prevention and Wellness Research, Baptist Health Medical Group, 1691 Michigan Avenue, Suite 500, Miami Beach, FL 33139, USA. 8. The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD, USA Center for Prevention and Wellness Research, Baptist Health Medical Group, 1691 Michigan Avenue, Suite 500, Miami Beach, FL 33139, USA Department of Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida Department of Epidemiology, Robert Stempel College of Public Health, Florida International University, Miami, Florida khurramn@baptisthealth.net knasir1@jhmi.edu.
Abstract
AIMS: We sought to evaluate the impact of coronary artery calcium (CAC) in individuals at the extremes of risk factor (RF) burden. METHODS AND RESULTS: 6698 individuals from the Multi-Ethnic Study of Atherosclerosis (MESA) were followed for coronary heart disease (CHD) events over mean 7.1 ± 1 years. Annualized CHD event rates were compared among each RF category (0, 1, 2, or ≥3) after stratification by CAC score (0, 1-100, 101-300, and >300). The following traditional modifiable RFs were considered: cigarette smoking, LDL cholesterol ≥3.4 mmol/L, low HDL cholesterol, hypertension, and diabetes. There were 1067 subjects (16%) with 0 RFs, whereas 1205 (18%) had ≥3 RFs. Among individuals with 0 RFs, 68% had CAC 0, whereas 12 and 5% had CAC >100 and >300, respectively. Among individuals with ≥3 RFs, 35% had CAC 0, whereas 34 and 19% had CAC >100 and >300, respectively. Overall, 339 (5.1%) CHD events occurred. Individuals with 0 RFs and CAC >300 had an event rate 3.5 times higher than individuals with ≥3 RFs and CAC 0 (10.9/1000 vs. 3.1/1000 person-years). Similar results were seen across categories of Framingham risk score. CONCLUSION: Among individuals at the extremes of RF burden, the distribution of CAC is heterogeneous. The presence of a high CAC burden, even among individuals without RFs, is associated with an elevated event rate, whereas the absence of CAC, even among those with many RF, is associated with a low event rate. Coronary artery calcium has the potential to further risk stratify asymptomatic individuals at the extremes of RF burden. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: We sought to evaluate the impact of coronary artery calcium (CAC) in individuals at the extremes of risk factor (RF) burden. METHODS AND RESULTS: 6698 individuals from the Multi-Ethnic Study of Atherosclerosis (MESA) were followed for coronary heart disease (CHD) events over mean 7.1 ± 1 years. Annualized CHD event rates were compared among each RF category (0, 1, 2, or ≥3) after stratification by CAC score (0, 1-100, 101-300, and >300). The following traditional modifiable RFs were considered: cigarette smoking, LDL cholesterol ≥3.4 mmol/L, low HDL cholesterol, hypertension, and diabetes. There were 1067 subjects (16%) with 0 RFs, whereas 1205 (18%) had ≥3 RFs. Among individuals with 0 RFs, 68% had CAC 0, whereas 12 and 5% had CAC >100 and >300, respectively. Among individuals with ≥3 RFs, 35% had CAC 0, whereas 34 and 19% had CAC >100 and >300, respectively. Overall, 339 (5.1%) CHD events occurred. Individuals with 0 RFs and CAC >300 had an event rate 3.5 times higher than individuals with ≥3 RFs and CAC 0 (10.9/1000 vs. 3.1/1000 person-years). Similar results were seen across categories of Framingham risk score. CONCLUSION: Among individuals at the extremes of RF burden, the distribution of CAC is heterogeneous. The presence of a high CAC burden, even among individuals without RFs, is associated with an elevated event rate, whereas the absence of CAC, even among those with many RF, is associated with a low event rate. Coronary artery calcium has the potential to further risk stratify asymptomatic individuals at the extremes of RF burden. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: J Jeffrey Carr; Jennifer Clark Nelson; Nathan D Wong; Michael McNitt-Gray; Yadon Arad; David R Jacobs; Stephan Sidney; Diane E Bild; O Dale Williams; Robert C Detrano Journal: Radiology Date: 2005-01 Impact factor: 11.105
Authors: Erin D Michos; Chandrasekhar R Vasamreddy; Diane M Becker; Lisa R Yanek; Taryn F Moy; Elliot K Fishman; Lewis C Becker; Roger S Blumenthal Journal: Am Heart J Date: 2005-12 Impact factor: 4.749
Authors: Rajesh Tota-Maharaj; Michael J Blaha; John W McEvoy; Roger S Blumenthal; Evan D Muse; Matthew J Budoff; Leslee J Shaw; Daniel S Berman; Jamal S Rana; John Rumberger; Tracy Callister; Juan Rivera; Arthur Agatston; Khurram Nasir Journal: Eur Heart J Date: 2012-07-26 Impact factor: 29.983
Authors: Robert Detrano; Alan D Guerci; J Jeffrey Carr; Diane E Bild; Gregory Burke; Aaron R Folsom; Kiang Liu; Steven Shea; Moyses Szklo; David A Bluemke; Daniel H O'Leary; Russell Tracy; Karol Watson; Nathan D Wong; Richard A Kronmal Journal: N Engl J Med Date: 2008-03-27 Impact factor: 91.245
Authors: Shaista Malik; Matthew J Budoff; Ronit Katz; Roger S Blumenthal; Alain G Bertoni; Khurram Nasir; Moyses Szklo; R Graham Barr; Nathan D Wong Journal: Diabetes Care Date: 2011-08-15 Impact factor: 19.112
Authors: Colin Baigent; Lisa Blackwell; Rory Collins; Jonathan Emberson; Jon Godwin; Richard Peto; Julie Buring; Charles Hennekens; Patricia Kearney; Tom Meade; Carlo Patrono; Maria Carla Roncaglioni; Alberto Zanchetti Journal: Lancet Date: 2009-05-30 Impact factor: 79.321
Authors: Michael J Blaha; Miguel Cainzos-Achirica; Philip Greenland; John W McEvoy; Ron Blankstein; Matthew J Budoff; Zeina Dardari; Christopher T Sibley; Gregory L Burke; Richard A Kronmal; Moyses Szklo; Roger S Blumenthal; Khurram Nasir Journal: Circulation Date: 2016-01-22 Impact factor: 29.690
Authors: Kazuhiro Osawa; Rine Nakanishi; Robyn L McClelland; Joseph F Polak; Warrick Bishop; Ralph L Sacco; Indre Ceponiene; Negin Nezarat; Sina Rahmani; Hong Qi; Mitsuru Kanisawa; Matthew J Budoff Journal: Atherosclerosis Date: 2018-05-17 Impact factor: 5.162
Authors: Mahmoud Al Rifai; Philip Greenland; Michael J Blaha; Erin D Michos; Khurram Nasir; Michael D Miedema; Joseph Yeboah; Veit Sandfort; Alexis C Frazier-Wood; Steven Shea; Joao Ac Lima; Moyses Szklo; Wendy S Post; Roger S Blumenthal; John W McEvoy Journal: Am Heart J Date: 2017-11-11 Impact factor: 4.749
Authors: Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner Journal: Circulation Date: 2017-01-25 Impact factor: 29.690
Authors: Miguel Cainzos-Achirica; Philip A Di Carlo; Catherine E Handy; Renato Quispe; Gerard Roura; Xavier Pinto; Roger S Blumenthal; Josep Comin-Colet; Xavier Corbella; Michael J Blaha Journal: Curr Cardiol Rep Date: 2018-07-10 Impact factor: 2.931
Authors: Nivee P Amin; Seth S Martin; Michael J Blaha; Khurram Nasir; Roger S Blumenthal; Erin D Michos Journal: J Am Coll Cardiol Date: 2014-05-07 Impact factor: 24.094
Authors: S Divakaran; M K Cheezum; E A Hulten; M S Bittencourt; M G Silverman; K Nasir; R Blankstein Journal: Br J Radiol Date: 2014-12-12 Impact factor: 3.039